Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Proven
neurotechnology
built for the
real world
Control Bionics delivers objective, non-invasive neural-signal technology, proven in clinical environments, and built to scale across performance, rehabilitation, medical, research, and assistive communication.
Capability
From signal to actionable insight
The Control Bionics neural-signal platform captures physiological data with medical-grade precision and converts it into measurable, decision-ready outcomes. Built for deployment across clinical, research, and performance environments — and validated where it counts.
Signal acquisition and processing
Real-time analysis and validation
Clinical integration and reporting
Technology
The platform serves distinct markets with precision and measurable outcomes. One underlying technology - four applications.
A platform built for clinical deployment
Medical-grade signal processing meets real-world clinical environments. Designed for integration, validation, and measurable outcomes.
Non-invasive neural signal capture
Physiological data without surgical intervention or implantation. Validated for use in complex clinical environments.
Regulatory pathway established
Cleared for clinical use with ongoing validation across multiple applications — FDA, TGA, and CE registered.
Outcome-focused architecture
Platform designed to deliver decision-ready insights, not only raw data. Built to integrate into clinical and research workflows.
Evidence from clinical and research deployment
Control Bionics technology is validated through research, clinical trials, and real-world deployment across rehabilitation, performance, and research settings.
1,000s of users
Trusted by individuals, clinicians, and organisations across four markets
Government and privately funded
Approved for funding through Medicare, Medicaid, NDIS, and private insurance pathways.
100%
Non-invasive signal acquisition
3 Regulatory clearances
(FDA, TGA, CE)
Latest from our platform
Research, clinical validation and platform developments.
Oskol 2: Eye Gaze Communication, Redefined
At Control Bionics, our mission is to deliver AAC technology that adapts to the needs of every user. With the launch of Oskol 2, we’re proud to introduce a new generation of speech-generating devices — designed exclusively for the 13″ iPad Air and powered by Hiru, the world’s first multiplatform eye-tracker.
We’re Headed to Closing The Gap 2025!
We’re thrilled to share that Control Bionics will be exhibiting and presenting at the 43rd Annual Closing The Gap Conference, taking place October 21–24, 2025 at the DoubleTree by Hilton in Bloomington, Minnesota. This event brings together the best minds in assistive...
Control Bionics Sponsors AACGameplay.com
Accessible Gaming for All Control Bionics is excited to announce our sponsorship of AACGameplay.com, a free online resource designed for therapists, teachers, and anyone supporting switch users. It is an updated, redesigned version of a much-loved Gameplay site...
Introducing The Block: A New AAC Resource Exclusively from Control Bionics
At Control Bionics, we believe that every voice deserves to be heard—clearly, confidently, and in a way that works for the communicator. That’s why we’re excited to introduce The Block, a new AAC vocabulary pageset distributed exclusively by Control Bionics,...
Select your path to neural-signal insights and outcomes
Explore how the platform integrates into clinical workflows and delivers decision-ready outcomes.
Learn more
Discover how researchers are using real-time neural data to power breakthrough studies.
LearnNDIS-registered provider
Control Bionics is a registered NDIS provider. Eligible participants can access our assistive communication devices and neurotechnology solutions through their NDIS plan.